Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 1:10 AM
NCT ID:
NCT06253793
Eligibility Criteria:
Inclusion criteria for all groups
* native language: French
* oral consent of the child, if able to do so, written consent of 2 parents or legal guardians
Inclusion criteria for the ASD experimental and control groups:
-ASD Diagnosis The diagnosis of ASD is clinical and is made by the referring physician. It is based on the DSM 5 and the clinical assessment of each patient.
Inclusion criteria for the ASD experimental group:
* absence of neurological pathology (epilepsy, etc.) and known genetic syndrome on admission
* written consent of 2 parents or legal guardians
Non-inclusion criteria for all children:
\- primary hearing and visual impairment (unless fully corrected).
Non-inclusion criteria for DT children only:
\- a known neurodevelopmental, neurological or psychiatric disorder.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Months
Maximum Age:
5 Years
Study:
NCT06253793
Study Brief:
Protocol Section:
NCT06253793